Ok Nam Li

Ok Nam Li

Auto-generated profile, based on publicly available information

Ok Nam Li

Vorokhobov City Clinical Hospital No. 67, Moscow Healthcare Department

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2025 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
AKA. L. Karpova
A. L. Karpova
Aleksei MostovoiAleksei Mostovoi
Aleksei Mostovoi
MPM. A. Ponimanskaya
M. A. Ponimanskaya
OLO. N. Lee
O. N. Lee
KDK. A. Desyatnik
K. A. Desyatnik
AKA. S. Kuznetsova
A. S. Kuznetsova
Introduction. One out of 10 patients with preterm labor exhibits signs of intra-amniotic inflammation, which often occurs subclinically and results in increased risk of premature rupture of membranes (PROM).Aim: to identify predictors of unfavorable perinatal outcomes associated with PROM.Materials and Мethods. The single-center retrospective cohort study was conducted from January 1 to November 1, 2023 by enrolling patients between 28 0/7 and 36 6/7 weeks of gestation with PROM. A total of 176 maternal and neonatal medical records were analyzed. Two groups of neonates were identified:Group 1 – neonates with favorable outcomes at the time of hospital discharge; Group 2 – fetuses or neonates with unfavorable outcomes at discharge (including antenatal fetal death, neonatal death, grade 3 intraventricular hemorrhage, periventricular leukomalacia, severe bronchopulmonary dysplasia, or surgical-stage necrotizing enterocolitis). There were analyzed maternal medical histories, pregnancy and delivery data, amniotic fluid index (AFI), maximum vertical pocket of amniotic fluid, severity of respiratory failure and central hemodynamic disturbances in premature neonates, as well as incidence rates for those born to mothers with PROM. Multivariate analysis was conducted to identify factors associated with neonatal outcomes.Results. Antenatal fetal death was recorded in 7 of 176 cases (3.9 %), and neonatal mortality among live-born infants comprised 7 of 169 (4.1 %). Median gestational age at delivery in Group 2 was 193.0 days [IQR: 180.0–198.0], significantly lower than in Group 1 (238.0 days [IQR: 223.5–247.0], p < 0.001). Chorioamnionitis (p < 0.001) and anhydramnion (p = 0.003) were significantly more frequent in Group 2. Neonates in Group 2 required tracheal intubation (p < 0.001), surfactant therapy (p < 0.001), mechanical ventilation (p = 0.029), and high-frequency oscillatory ventilation (p < 0.001) more often within the first 72 hours of life. NEOMOD (Neonatal Multiple Organ Dysfunction) scores were significantly higher in this group (p < 0.001). In Group 2, Ureaplasma parvum in nasopharyngeal swabs was more frequently found by using polymerase chain reaction (p = 0.015).Conclusion. Predictors of adverse outcomes in fetuses and preterm neonates with PROM consisted of anhydramnios, chorioamnionitis, lower gestational age and birth weight, cesarean delivery, elevated maternal C-reactive protein (CRP) and white blood cell count prior to delivery, an AFI ≤ 32.0 mm, higher NEOMOD scores, presence of diffuse ecchymosis at birth, detection of neonatal Ureaplasma parvum, lower hemoglobin levels, as well as increased procalcitonin and CRP levels within the first 72 hours of life.

15 May 2026 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
AOA. R. Oskolkova
A. R. Oskolkova
AKA. A. Krivulyak
A. A. Krivulyak
AKA. R. Komelkova
A. R. Komelkova
VBVictoria Bitsadze
Victoria Bitsadze
JKJamilya Khizroeva
Jamilya Khizroeva
AMAlexander Makatsariya
Alexander Makatsariya
Preeclampsia (PE) is not only an acute obstetric complication but also a significant factor in long-term cardiovascular risk. This article analyzes the pathogenetic mechanisms linking recurrent severe PE with the development of chronic arterial hypertension, coronary heart disease, stroke, and heart failure in the long-term. Particular attention is paid to the two-stage PE model, as well as the key role for immune-inflammatory responses, oxidative stress, and hemostatic disorders. Recurrent PE is shown to cause cumulative damage to the vascular bed, transforming acute inflammation into chronic cardiovascular pathology. Neutrophil extracellular traps collectively resulting in innate immune activation, hypercoagulability, and endothelial damage, play a central role in the pathogenesis. Current approaches to preventing recurrent PE such as aspirin, calcium supplements, and low-molecular-weight heparins are discussed.

10 May 2026 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Closed access
DBDmitry V. Blinov
Dmitry V. Blinov
ASA. G. Solopova
A. G. Solopova
VBVictoria Bitsadze
Victoria Bitsadze
JKJamilya Khizroeva
Jamilya Khizroeva
MTMaria V. Tretyakova
Maria V. Tretyakova
AMAlexander Makatsariya
Alexander Makatsariya
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), remains a global health challenge. Modern advances in the management of acute VTE, such as the introduction of direct oral anticoagulants and interventional techniques, have led to a significantly decreased mortality rate, that however was simultaneously accounted for by a growing population of patients living with long-term disabling sequelae. The key complications are post-thrombotic syndrome (PTS) developing in 20–50 % of DVT patients that manifests as chronic venous insufficiency, edema, pain, and venous ulcers as well as chronic thromboembolic pulmonary hypertension (CTEPH), which occurs in up to 4.0 % of PE survivors and leads to progressive dyspnea, heart failure, and reduced exercise tolerance. The pathogenesis of these conditions is based on incomplete vein recanalization, valvular damage, persistent inflammation, and endothelial dysfunction in PTS, as well as thrombus organization and pulmonary vascular remodeling resulting in right heart failure in CTEPH. This article emphasizes the necessity to shift from an acute-event treatment model to a continuous chronic disease management paradigm. Effective rehabilitation requires a comprehensive multidisciplinary assessment, utilizing subjective scales and questionnaires alongside objective methods (duplex ultrasound, echocardiography, and cardiopulmonary exercise testing). Key components of a rehabilitation program include optimization of anticoagulation, nutritional support, compression therapy, early mobilization, and structured physical training to enhance the muscle-venous pump mechanism and cardiorespiratory fitness, as well as psychosocial support and lifestyle modification. VTE rehabilitation despite obvious demand faces a lack of standardized protocols, a scarcity of high-quality research, and unequal access to specialized care. Future directions include personalizing programs through risk stratification, utilizing telemedicine to improve treatment adherence, and developing clinical guidelines focused on long-term functional recovery and improved patients’ quality of life.

1 January 2022 in Endocrinology: News, Opinions, Training
Verified
Journal Article
Closed access
MPMoscow City Clinical Hospital Named After D.D. Pletnev
Moscow City Clinical Hospital Named After D.D. Pletnev
MPM.A. Ponimanskaya
M.A. Ponimanskaya
NSN.M. Startseva
N.M. Startseva
OLOk Nam Li
Ok Nam Li
SSS.Z. Sanaya
S.Z. Sanaya
Оценка состояния плода в родах: противоречия и перспективы

5 July 2024 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
AMAlexander Makatsariya
Alexander Makatsariya
AVAlexander Vorobev
Alexander Vorobev
ALArina Lazarchuk
Arina Lazarchuk
SESabina Einullaeva
Sabina Einullaeva
NGN. A. Gomenko
N. A. Gomenko
Ismail ElalamyIsmail Elalamy
Ismail Elalamy
Compared to children of other ages, neonates especially seriously ill and premature subjects comprise a high thrombotic risk group. A decline in the incidence of neonatal thrombosis may be accounted for by improved treatment of severe conditions in newborns and increased survival of premature infants. Neonatal and adult hemostasis exhibit distinct physiological features: difference in concentration, synthesis rate of blood coagulation factors, metabolic rate, thrombin and plasmin levels. At the same time, neonatal threshold values for natural blood coagulation inhibitors (protein C, protein S, antithrombin, heparin cofactor II) and vitamin K-dependent coagulation factors (FII, FVII, FIX, FX) are quite low, whereas that of FVIII and von Willebrand factor exceeds those found in adults. Thus, newborns have lower plasma fibrinolytic activity. The main risk factors for developing thrombotic complications are as follows: central venous catheters, altered body fluid volume, liver disease, as well as sepsis and inflammatory processes particularly COVID-19. The significance of congenital and acquired maternal and neonatal thrombophilia may pose an additional risk factor for thrombotic complications. Low-molecular weight heparins are the first-choice drugs in treatment and prevention of neonatal thrombosis.

7 May 2026 in V.F.Snegirev Archives of Obstetrics and Gynecology
Verified
Journal Article
Open access
IBInga Akopovna Bulatova
Inga Akopovna Bulatova
MSMadina Sheralievna Salanova
Madina Sheralievna Salanova
MPMaria Alexandrovna Ponimanskaya
Maria Alexandrovna Ponimanskaya
OLOk Nam Li
Ok Nam Li
KDKirill Alexandrovich Desyatnik
Kirill Alexandrovich Desyatnik
OPOlga Borisovna Panina
Olga Borisovna Panina
BACKGROUND.Despite the increasing rate of labor induction, particularly for fetal and maternal indications, the contribution of specific obstetric complications to the risk of failed induction remains insufficiently studied. Existing research primarily compares induction with expectant management or spontaneous labor in the presence of a given pathology. This study aimed to address this gap by analyzing various indications within a single cohort. OBJECTIVE.To analyze indications for labor induction and evaluate its effectiveness. METHODS.Medical records of 1571 women with singleton pregnancies undergoing induction at ≥37 weeks were analyzed. Patients were stratified by indication: gestational age ≥41 weeks, gestational diabetes mellitus, gestational hypertension, large fetus, moderate preeclampsia, chronic hypertension, polyhydramnios, oligohydramnios, intrahepatic cholestasis of pregnancy, complicated obstetric history, and fetal growth restriction. Successful induction was defined as vaginal delivery. RESULTS.The overall cesarean section rate following induction was 21% (n=327): 26% (n=294) in nulliparous and 8% (n=33) in multiparous women. The highest risk of failed induction was observed for chronic hypertension in nulliparous women (p=0.005; OR 1.95; 95% CI 1.21–3.15); for moderate preeclampsia and complicated obstetric history in multiparous women (p=0.010; OR 3.39; 95% CI 1.28–9.00 and p0.001; OR 6.44; 95% CI 2.27–18.29, respectively). Successful induction was associated with intrahepatic cholestasis in nulliparous women (p=0.043; OR 0.35; 95% CI 0.12–1.01). A large fetus as the sole indication significantly increased the cesarean section risk (p=0.004; OR 1.84; 95% CI 1.21–2.81); however, as a coexisting condition with other pathologies, its predictive value disappeared (p=0.237; OR 0.56; 95% CI 0.19–1.61). In multiparous women, induction outcome was most accurately predicted by considering multiple factors (BF₁₀ = 3.58, R² = 0.073). CONCLUSION.In nulliparous women, failed induction risk is increased with chronic hypertension and decreased with intrahepatic cholestasis. In multiparous women, outcome was determined by a combination of factors. A large fetus as a coexisting condition did not increase cesarean section risk. The diagnosis of a large fetus, as the sole indication, increases the risk of cesarean section, but as a coexisting condition with other indications, it does not contribute to the outcome.